Effects of sphingolipid metabolism disorders on endothelial cells

Yali Lai1, Yue Tian1, Xintong You1

  • 1School of Traditional Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China.

Insights

Sphingolipid metabolism critically impacts endothelial cell function in cardiovascular diseases. Dysregulation of sphingolipids like ceramide (Cer) and sphingosine-1-phosphate (S1P) offers insights into disease mechanisms and potential therapeutic targets.

Area of Science:

  • Cardiovascular Biology
  • Cellular Metabolism
  • Endothelial Function

Background:

  • Endothelial cell dysfunction is a hallmark of numerous cardiovascular disorders, including atherosclerosis, hypertension, and diabetes.
  • Sphingolipid metabolism plays a crucial role in maintaining endothelial cell homeostasis and function.
  • Aberrant sphingolipid metabolism is increasingly recognized as a contributor to cardiovascular pathology.

Purpose of the Study:

  • To review the multifaceted roles of sphingolipid metabolites and enzymes in endothelial cell function.
  • To elucidate the impact of dysregulated sphingolipid metabolism on cardiovascular health.
  • To identify potential therapeutic targets within sphingolipid pathways for cardiovascular diseases.

Main Methods:

  • Literature review synthesizing current research on sphingolipids and endothelial cells.
  • Analysis of the effects of key sphingolipid metabolites (e.g., sphingosine, ceramide, S1P) and enzymes (e.g., SPHK, Cerk, S1PL).
  • Examination of studies linking sphingolipid metabolism alterations to cardiovascular disease pathogenesis.

Main Results:

  • Sphingolipids, including ceramide (Cer) and sphingosine-1-phosphate (S1P), exert diverse effects, both protective and damaging, on endothelial cells.
  • Enzymes involved in sphingolipid metabolism, such as sphingosine kinase (SPHK) and sphingosine-1-phosphate lyase (S1PL), are critical regulators of endothelial function.
  • Disruptions in sphingolipid metabolism are directly implicated in the development and progression of cardiovascular diseases.

Conclusions:

  • Sphingolipid metabolism is a vital determinant of endothelial cell health and cardiovascular disease progression.
  • Understanding the complex interplay between sphingolipids and endothelial cells is essential for developing novel therapeutic strategies.
  • Targeting specific enzymes or metabolites in the sphingolipid pathway holds promise for treating cardiovascular disorders.

Related Concept Videos

Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
2.1K
Asymmetric Lipid Bilayer01:35

Asymmetric Lipid Bilayer

Biological membranes show uneven distribution of different types of lipids in the inner and outer layers, resulting in transverse asymmetric membranes. The treatment of the erythrocyte membrane with the enzyme phospholipase confirmed the asymmetric nature of the lipid bilayer. The enzyme hydrolyzes lipids into fatty acids and hydrophilic groups. The phospholipase acts only on the outer layer of the membrane, while the inner layer remains intact. The phospholipase treatment resulted in 80%...
7.5K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
224
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.9K
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
269
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
1.1K